NAKU
DEAD

Serial Number

99889749

Owner

Ferring B.V.

Attorney

Joyce M. Ferraro

Filing Date

Jun 17, 2026

Add to watchlist:

No watchlists yet
View on USPTO

NAKU Trademark

Serial Number: 99889749

NAKU is a trademark filed by Ferring B.V. on June 17, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Ferring B.V. (8 trademarks)

Polarisavenue 144
Hoofddorp NL-2132JX , NL

Entity Type: 16

Trademark Details

Filing Date

June 17, 2026

Registration Date

Not Registered

Goods & Services

Biological preparations for use in the pharmaceutical industry; biological preparations for scientific and research use; biological cell preparations for use in the pharmaceutical industry and for laboratory and scientific use; T-cells and gamma delta T-cells for use in the pharmaceutical industry and for laboratory and scientific use; cell cultures for use in the pharmaceutical industry and for laboratory and scientific use; biological materials for use in cellular engineering; biological materials for use in immunology research; cellular starting materials for use in the pharmaceutical industry and for laboratory and scientific use; biological preparations for use in the development of cellular therapies; biological materials for use in pharmaceutical and biomedical research

Pharmaceutical and biological preparations for medical and therapeutic use; cellular preparations for medical and therapeutic use; T-cells and gamma delta T-cells for medical and therapeutic use; genetically engineered cellular preparations for medical and therapeutic use; engineered immune cell preparations for medical and therapeutic purposes; biological preparations for use in cellular therapy; cell-based therapeutic preparations; cellular therapeutic preparations for the treatment of cancer, infectious diseases and immune-related disorders

Pharmaceutical and biomedical research and development services; scientific research and development in the field of biotechnology, immunology, cell therapy, immunotherapy and regenerative medicine; scientific research relating to immune cells, T-cells, gamma delta T-cells, adoptive cell therapies and cancer therapies; laboratory research relating to cellular and genetic engineering; development of engineered immune cells and cellular therapeutic products for therapeutic applications; laboratory services relating to biotechnology and cellular manipulation; clinical research services; scientific consultancy relating to biotechnology, immunotherapy and pharmaceutical development; providing scientific information relating to cellular therapies and immunotherapeutics

Filing History

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Aug 26, 2026 MAB1
ABANDONMENT - EXPRESS MAILED
Aug 26, 2026 ABN1
ASSIGNED TO EXAMINER
Aug 26, 2026 DOCK
TEAS EXPRESS ABANDONMENT RECEIVED
Aug 19, 2026 EXAR
APPLICATION FILING RECEIPT MAILED
Jun 17, 2026 MAFR
NEW APPLICATION ENTERED
Jun 17, 2026 NWAP